Biotech company Complement Therapeutics, which has facilities at Stevenage Bioscience Catalyst, has received a major ...

Complement Therapeutics GmbH (CTx), a biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) ...

Complement Therapeutics receives US FDA clearance to begin Opti-GAIN phase I/II trial of CTx001 in patients with GA secondary to AMD: Munich, Germany Thursday, October 9, 2025, 11 ...

The National Radio and Television Administration has introduced new measures aimed at revitalizing the country's flagging ...

Anti-Muslim extremists and Muslim extremists appear to be sworn enemies, yet both are reflections of the same delusion.

This digital piano learning system is designed for anyone, from complete beginners to intermediate players. It combines ...

That’s Callaway Vineyard & Winery in Temecula, California – a slice of Mediterranean paradise that makes you question whether you’ve accidentally teleported to Tuscany. I’ve spent years searching for ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, will present data ...

This is the first in a four-part series. The world is in the early stages of the next industrial revolution: quantum ...

Objective Glomerular immune complex deposition plays a central role in lupus nephritis (LN), but the prognostic relevance of individual immunoglobulin components remains unclear. This study aimed to ...